Artificial Intelligence In Pathology Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Will the Artificial Intelligence In Pathology Market Grow, and What Is the Projected Market Size?
The market size for artificial intelligence in pathology has seen significant growth in the past few years. The market is projected to expand from $1.22 billion in 2024 to $1.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.8%. The growth observed in the historical period is a result of several factors, including increased disease prevalence, augmented funding initiatives, a rise in telemedicine use, more government initiatives, and growing demand for pathology services.

The market for artificial intelligence in pathology is projected to experience swift expansion in the coming years. By 2029, its value is anticipated to be $2.31 billion, with a compound annual growth rate (CAGR) of 13.5%. This growth during the prediction period can be ascribed to factors such as the expanding role of AI in clinical trials, improvements in healthcare infrastructure, interdisciplinary cooperation, the formulation of clearly defined ethical guidelines, and the creation of AI-fueled predictive analytics. Noteworthy trends during this forecast period are expected to include the invention of AI-based diagnostic instruments, their amalgamation with electronic health records, computer-assisted diagnoses (CAD), the unearthing of AI-dependent biomarkers, and genomic data integration.

What Key Elements Are Boosting Growth in the Artificial Intelligence In Pathology Market?
The demand for customized healthcare solutions is predicted to fuel the expansion of the artificial intelligence in the pathology market. Customized healthcare involves adapting treatments and medical care to the unique attributes, requirements, and wants of every patient. This escalating demand is prompted by the ability to adapt treatments to specific genetic profiles, aspects of lifestyle, and unique disease markers, thereby enhancing effectiveness and minimizing side effects. AI in pathology lends support to bespoke healthcare by facilitating a more precise and effective interpretation of medical imagery and genetic information. This leads to a more detailed diagnosis, improved disease subtype identification, and treatment strategies that echo the patient's specific biological profile. For example, in February 2023, the Personalized Medicine Coalition, a US-based professional association, released a report saying that 12 new customized medicines were approved in 2022, comprising approximately 34% of all new therapies. This displays a substantial increase compared to earlier years. Hence, the rising demand for customized healthcare is propelling the expansion of the artificial intelligence in pathology market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18960&type=smp

Who Are the Major Industry Players Fueling Artificial Intelligence In Pathology Market Expansion?
Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc., Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Which Key Developments Are Influencing the Artificial Intelligence In Pathology Market?
Key players in the artificial intelligence in pathology market are prioritizing the development of cutting-edge solutions like advanced tools for cancer detection. The objective here is to streamline operations, improve diagnostic precision, and enhance patient results. These advanced cancer detection applications use AI to apply machine learning algorithms and deep learning models to the analysis of medical imagery and pathological slides, in turn improving the precision of tumor detection and categorization. Paige.ai is a prime example - this US digital pathology firm introduced the Paige Lymph Node Module in March 2022 to aid pathologists in identifying metastases in lymph nodes resulting from breast cancer. Notable features include greater than 98% sensitivity in detecting any size of breast cancer metastases, even tiny micrometastases. Plus, the proprietary TissueMap feature helps highlight suspicious areas on lymph node slides. This not only improves the accuracy and speed of pathology reviews, but it also significantly cuts down on the time needed to analyze these slides.

How Is the Segmentation of the Artificial Intelligence In Pathology Market Defined?
The artificial intelligence in pathologymarket covered in this report is segmented -

1) By Component: Software, Scanners
2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks
3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education
4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes

Subsegments:
1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software
2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-pathology-global-market-report

What Is the Leading Region in the Artificial Intelligence In Pathology Market?
Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Artificial Intelligence In Pathology Global Market Report?

- Market Size Analysis: Analyze the Artificial Intelligence In Pathology Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Artificial Intelligence In Pathology Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Artificial Intelligence In Pathology Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Artificial Intelligence In Pathology Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18960

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.